Gastroenterology
Volume 136, Issue 1 , Pages 288-298, January 2009

Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium

  • Maud Pinier

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
  • ,
  • Elena F. Verdu

      Affiliations

    • Intestinal Disease Research Programme, Faculty of Health Sciences, McMaster University, Hamilton, Canada
  • ,
  • Mohamad Nasser–Eddine

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
  • ,
  • Chella S. David

      Affiliations

    • Department of Immunology, Mayo Clinic, Rochester, New York
  • ,
  • Anne Vézina

      Affiliations

    • CIHR Team in Digestive Epithelium, Department of Anatomy and Cellular Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
  • ,
  • Nathalie Rivard

      Affiliations

    • CIHR Team in Digestive Epithelium, Department of Anatomy and Cellular Biology, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Canada
  • ,
  • Jean–Christophe Leroux

      Affiliations

    • Faculty of Pharmacy, University of Montreal, Montreal, Canada
    • Corresponding Author InformationAddress requests for reprints to: Jean–Christophe Leroux, Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada. fax: (514) 343-6455

Received 22 February 2008; accepted 11 September 2008. published online 22 September 2008.

Background & Aims

Celiac disease is a prevalent immune disorder caused by the ingestion of gliadin-containing grains. We investigated the ability of a polymeric binder to reverse the toxic effects induced by gliadin in human intestinal cells and gliadin-sensitive HCD4-DQ8 mice.

Methods

Gliadin was neutralized by complexation to a linear copolymer of hydroxyethylmethacrylate (HEMA) and sodium 4-styrene sulfonate (SS). The ability of the polymeric binder to abrogate the damaging effect of gliadin on cell-cell contact was investigated in IEC-6, Caco-2/15, and primary cultured differentiated enterocytes. The efficacy of the polymeric binder in preventing gliadin-induced intestinal barrier dysfunction was assessed using gliadin-sensitive HLA-HCD4/DQ8 transgenic mice.

Results

Poly(hydroxyethylmethacrylate-co-styrene sulfonate) [P(HEMA-co-SS)] complexed with gliadin in a relatively specific fashion. Intestinal cells exposed to gliadin underwent profound alterations in morphology and cell-cell contacts. These changes were averted by complexing the gliadin with P(HEMA-co-SS). More importantly, the P(HEMA-co-SS) hindered the digestion of gliadin by gastrointestinal enzymes, thus minimizing the formation of immunogenic peptides. Coadministration of P(HEMA-co-SS) with gliadin to HLA-HCD4/DQ8 mice attenuated gliadin-induced changes in the intestinal barrier and reduced intraepithelial lymphocyte and macrophage cell counts.

Conclusions

Polymeric binders can prevent in vitro gliadin-induced epithelial toxicity and intestinal barrier dysfunction in HCD4/DQ8 mice. They have a potential role in the treatment of patients with gluten-induced disorders.

Abbreviations used in this paper: CD, celiac disease, HEMA, hydroxyethylmethacrylate, HLA, human leukocyte antigen, HRP, horseradish peroxidase, IEL, intraepithelial lymphocyte, PCDE, primary cultures of human differentiated enterocytes, PEG, poly(ethylene glycol), P(HEMA-co-SS), poly(hydroxyethylmethacrylate-co-styrene sulfonate), PSS, polystyrene sulfonate, SS, styrene sulfonate, ZO-1, zonula occludens-1

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors disclose the following: Supported by the Canadian Celiac Association, Fonds Québécois de la Recherche sur la Nature et les Technologies, Canadian Institutes of Health Research (to N.R.), National Institutes of Health DK 071003 (to C.S.D.), CAG/CIHR New Investigator Establishment Award (to E.F.V.), and the Canada Research Chair program.

PII: S0016-5085(08)01681-8

doi:10.1053/j.gastro.2008.09.016

Refers to erratum:

  • Correction , 31 October 2011

    Gastroenterology January 2012 (Vol. 142, Issue 1, Page 186)

Gastroenterology
Volume 136, Issue 1 , Pages 288-298, January 2009